LANCE ALSTODT - 13 Feb 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
President, CEO, COB, Director, 10%+ Owner
Signature
/s/ Lance Alstodt
Issuer symbol
BRTX
Transactions as of
13 Feb 2024
Transactions value $
$0
Form type
4
Filing time
15 Feb 2024, 16:11:35 UTC
Previous filing
18 Sep 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BRTX Common Stock 189,505 13 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +438,596 $0 438,596 13 Feb 2024 Common Stock 438,596 $1.45 Direct F5
holding BRTX Stock Option 293,479 13 Feb 2024 Common Stock 293,479 $5.08 Direct F2
holding BRTX Stock Option 42,059 13 Feb 2024 Common Stock 42,059 $5.08 Direct F3
holding BRTX Stock Option 106,762 13 Feb 2024 Common Stock 106,762 $2.91 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
F2 The option is currently exercisable.
F3 The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
F4 The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
F5 The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.